Solid Biosciences (NASDAQ:SLDB – Free Report) had its price objective boosted by Chardan Capital from $15.00 to $16.00 in a report published on Wednesday morning,Benzinga reports. The brokerage ...
Imagine a cancer treatment that precisely targets malignant cells, leaving healthy ones untouched. Consider, also, a cancer treatment that corrects abnormal protein synthesis to produce healthy ...
Opinion
8hon MSNOpinion
I'm fighting a fatal disease that took the life of my brother. I work in biotech and know there are medical advances that might help. Government needs to let us try.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback